Mapping and direct valuation: do they give equivalent EQ-5D-5L index scores?

被引:16
|
作者
Luo, Nan [1 ]
Cheung, Yin Bun [2 ,3 ,4 ]
Ng, Raymond [5 ]
Lee, Chun Fan [2 ,3 ]
机构
[1] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore
[2] Duke NUS Grad Med Sch, Ctr Quantitat Med, Singapore, Singapore
[3] Singapore Clin Res Inst, Dept Biostat, Singapore, Singapore
[4] Univ Tampere, Dept Int Hlth, FIN-33101 Tampere, Finland
[5] Natl Canc Ctr, Dept Med Oncol, Singapore, Singapore
来源
基金
新加坡国家研究基金会; 英国医学研究理事会;
关键词
QUALITY-OF-LIFE; BREAST-CANCER PATIENTS; FUNCTIONAL ASSESSMENT; CHINESE VERSIONS; FACT-B; DIABETES PATIENTS; UTILITY INDEX; HEALTH; QUESTIONNAIRE; THERAPY;
D O I
10.1186/s12955-015-0361-y
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objective: Utility values of health states defined by health-related quality of life instruments can be derived from either direct valuation ('valuation-derived') or mapping ('mapping-derived'). This study aimed to compare the utility-based EQ-5D-5L index scores derived from the two approaches as a means to validating the mapping function developed by van Hout et al for the EQ-5D-5L instrument. Methods: This was an observational study of 269 breast cancer patients whose EQ-5D-5L index scores were derived from both methods. For comparing discriminatory ability and responsiveness to change, multivariable regression models were used to estimate the effect sizes of various health indicators on the index scores. Agreement and test-retest reliability were examined using intraclass correlation coefficient (ICC). Whenever appropriate, the 90 % confidence intervals (90 % CI) were compared to predefined equivalence margins. Results: The mean difference in and ICC between the valuation-and mapping-derived EQ-5D-5L index scores were 0.015 (90 % CI = 0.006 to 0.024) and 0.915, respectively. Discriminatory ability and responsiveness of the two indices were equivalent in 13 of 15 regression analyses. However, the mapping-derived index score was lower than the valuation-derived index score in patients experiencing extreme health problems, and the test-retest reliability of the former was lower than the latter, for example, their ICCs differed by 0.121 (90 % CI = 0.051 to 0.198) in patients who reported no change in performance status in the follow-up survey. Conclusion: This study provided the first evidence supporting the validity of the mapping function for converting EQ-5D-5L profile data into a utility-based index score.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Instrument-Defined Estimates of the Minimally Important Difference for EQ-5D-5L Index Scores
    McClure, Nathan S.
    Al Sayah, Fatima
    Xie, Feng
    Luo, Nan
    Johnson, Jeffrey A.
    VALUE IN HEALTH, 2017, 20 (04) : 644 - 650
  • [42] Mapping health assessment questionnaire disability index onto EQ-5D-5L in China
    Wan, Chuchuan
    Wang, Qiqi
    Xu, Zhaoqi
    Huang, Yuankai
    Xi, Xiaoyu
    FRONTIERS IN PUBLIC HEALTH, 2023, 11
  • [43] Determinants of health preferences in the Canadian EQ-5D-5L Valuation Study
    Al Sayah, Fatima
    Bansback, Nick
    Bryan, Stirling
    Ohinmaa, Arto
    Pullenayegum, Eleanor
    Xie, Feng
    Johnson, Jeffrey A.
    QUALITY OF LIFE RESEARCH, 2015, 24 : 177 - 178
  • [44] RETRACTED: The EQ-5D-5L Valuation Study in Egypt (Retracted Article)
    Al Shabasy, Sahar A.
    Abbassi, Maggie M.
    Finch, Aureliano Paolo
    Baines, Darrin
    Farid, Samar F.
    PHARMACOECONOMICS, 2021, 39 (05) : 549 - 561
  • [45] COVID-19 and EQ-5D-5L health state valuation
    Edward J. D. Webb
    Paul Kind
    David Meads
    Adam Martin
    The European Journal of Health Economics, 2024, 25 : 117 - 145
  • [46] Quality control of the data on the Portuguese study for the valuation of the EQ-5D-5L
    Antunes, Patricia
    Ferreira, Pedro Lopes
    Ferreira, Lara Noronha
    Pereira, Luis
    QUALITY OF LIFE RESEARCH, 2018, 27 : S62 - S62
  • [47] Parallel Valuation of the EQ-5D-3L and EQ-5D-5L by Time Trade-Off in Hungary
    Rencz, Fanni
    Brodszky, Valentin
    Gulacsi, Laszlo
    Golicki, Dominik
    Ruzsa, Gabor
    Pickard, A. Simon
    Law, Ernest H.
    Pentek, Marta
    VALUE IN HEALTH, 2020, 23 (09) : 1235 - 1245
  • [48] A Comparison of the EQ-5D-3L and EQ-5D-5L
    Thompson, Alexander James
    Turner, Alex James
    PHARMACOECONOMICS, 2020, 38 (06) : 575 - 591
  • [49] A Comparison of the EQ-5D-3L and EQ-5D-5L
    Alexander James Thompson
    Alex James Turner
    PharmacoEconomics, 2020, 38 : 575 - 591
  • [50] Determinants of time trade-off valuations for EQ-5D-5L health states: data from the Canadian EQ-5D-5L valuation study
    Al Sayah, Fatima
    Bansback, Nick
    Bryan, Stirling
    Ohinmaa, Arto
    Poissant, Lise
    Pullenayegum, Eleanor
    Xie, Feng
    Johnson, Jeffrey A.
    QUALITY OF LIFE RESEARCH, 2016, 25 (07) : 1679 - 1685